Related Experiment Video

Updated: May 9, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity

Aaron Flanders, Maryalice Stetler-Stevenson, Ola Landgren

    Blood
    |August 10, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
    09:57

    Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

    Published on: March 5, 2018

    Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry
    10:58

    Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry

    Published on: March 5, 2019

    Related Experiment Videos

    Last Updated: May 9, 2026

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
    09:01

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

    Published on: March 26, 2018

    Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
    09:57

    Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

    Published on: March 5, 2018

    Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry
    10:58

    Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry

    Published on: March 5, 2019

    Related Concept Videos

    Flow Cytometry01:23

    Flow Cytometry

    The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
    In...

    Articles linked to this work by shared authors, journal, and citation graph.

    Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragments covalently deposited on lymphoma cells.

    Blood·2025

    EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma.

    Blood·2024

    Standardization of flow cytometric detection of antigen expression.

    Cytometry. Part B, Clinical cytometry·2024

    A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions.

    British journal of haematology·2022

    Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation.

    Journal for immunotherapy of cancer·2022

    Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.

    Blood advances·2022

    Nipocalimab for warm autoimmune hemolytic anemia: results from the phase 2/3 randomized, double-blind ENERGY study.

    Blood·2026

    Inhibition of nucleoporin 214 depletes leukemia stem cells by promoting heme catabolism and lipid peroxidation.

    Blood·2026

    International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

    Blood·2026

    Epigenetic markers expand genetic risk estimation in acute myeloid leukemia.

    Blood·2026

    Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

    Blood·2026

    T-cell immunosenescence limits CD19 CAR T-cell function in chronic lymphocytic leukemia.

    Blood·2026

    Mycoplasma mycoides subsp. capri encodes multiple pathways for hydrogen peroxide production.

    iScience·2026

    Amikacin Liposomal Inhalation Suspension: Advances in Application Against Refractory Mycobacterium avium Complex.

    Infection and drug resistance·2026

    Myeloid sarcoma of prostate: A case report and literature review.

    Urology case reports·2026

    Anti-gicerin Antibody Suppresses Early Pulmonary Metastatic Colonization of B16F10 Melanoma Cells.

    In vivo (Athens, Greece)·2026

    Culture-positive neck abscess masking metastatic squamous cell carcinoma: a diagnostic pitfall.

    BMJ case reports·2026

    Thigh abscess following alternate-site continuous glucose monitoring sensor placement.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us